Commentary on the 2015 Standards for Diabetes Care

Of the many recommendations in the American Diabetes Association's (ADA) updated Standards of Medical Care in Diabetes, 3 were chosen as particularly important for nonendocrinologists by the authors of a recent commentary in Annals of Internal Medicine.


Of the many recommendations in the American Diabetes Association's (ADA) updated Standards of Medical Care in Diabetes, 3 were chosen as particularly important for nonendocrinologists by the authors of a recent commentary in Annals of Internal Medicine.

First was the recommendation of a new body mass index cut point for prediabetes and type 2 diabetes screening in Asian Americans, reduced from 25 to 23 kg/m2. Second, the commentary authors highlighted the principle that patients' target HbA1c and choice of treatment strategy should be individualized, accounting for such factors as age, comorbid conditions, life expectancy, motivation, and preferences. The third topic was the new ADA recommendations on hypertension and statin therapy, which emphasize that physicians should treat patients' individual cardiovascular risk with statins and not just focus on number goals.

The new standards were published in Diabetes Care in January and summarized in the January ACP Diabetes Monthly. The commentary was published by Annals of Internal Medicine on March 24.

Annals of Internal Medicine's Diabetes Collection is available online.